Evolutionary Genomics Inc   (FNAM)
Other Ticker:  
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
Price: $0.4500 $-0.15 -25.000%
Day's High: $0.45 Week Perf: -30.77 %
Day's Low: $ 0.45 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.70
Volume (M$): $ 0 52 Wk Avg: $0.62
Open: $0.45 52 Wk Low: $0.45

 Market Capitalization (Millions $) 3
 Shares Outstanding (Millions) 6
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -2
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Evolutionary Genomics Inc
Evolutionary Genomics Inc is a biotechnology company specializing in evolutionary genomics research and analysis. It applies genomic technologies and computational algorithms to study the genetic variation and evolutionary history of various species, including humans, animals, and plants.

The company aims to improve the understanding of genetic diversity, adaptation, and evolutionary processes by analyzing large-scale genomic datasets. It develops advanced bioinformatics tools and algorithms to decipher the complex genetic code and identify key genomic variations that drive evolutionary changes.

Evolutionary Genomics Inc collaborates with academic institutions, research centers, and pharmaceutical companies to provide genomics services and assist in uncovering important genetic insights. Its services include genotyping, whole-genome sequencing, comparative genomics analysis, and evolutionary modeling.

The company's research findings and genomic discoveries have practical applications in various fields, including medicine, conservation biology, agriculture, and evolutionary biology. Its work contributes to the development of personalized medicine, conservation strategies, crop improvement, and understanding the fundamental processes that shape biodiversity.

Overall, Evolutionary Genomics Inc plays a crucial role in advancing our understanding of genetics, evolution, and their implications in various domains, with the aim of making significant contributions to scientific knowledge and practical applications in genomics research.

   Company Address: 4220 Morning Star Drive Castle Rock 80108 CO
   Company Phone Number: 900-8666   Stock Exchange / Ticker: FNAM


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Bionexus Gene Lab Corp

Income per Share Unaffected at the Bionexus Gene Lab Corp in the fourth quarter of 2023 earnings season

For the fourth quarter of 2023 earnings season BGLC earnings per share remained unchanged of $0.02 per share compare to $0.00 a year prior and earnings per share turned positive from $-0.16 per share from the previous quarter. The revenue receded considerably by -19.95 % to $2.27 million from $2.84 million in the comparable quarter a year prior and sequentially Revenue deteriorated by -10.989 % from $2.55 million.

American Shared Hospital Services

American Shared Hospital Services Reports Mixed Fourth Quarter Results

American Shared Hospital Services (AMS) recently released their financial results for the fourth quarter of 2023 earnings season, showcasing a mixed bag of performance metrics. While the company was able to significantly improve its earnings per share (EPS) by 133.24% to $0.06 per share, there were some concerning declines in revenue and net earnings.
In terms of revenue, AMS saw a decrease of -4.725% year on year, amounting to $4.80 million. This decrease was even more pronounced compared to the previous quarter, where revenue fell by -5.939% from $5.10 million. However, the bright spot for AMS was the substantial increase in EPS, which rose by 219.67% from $0.02 per share in the previous quarter.

Psychemedics Corporation

Challenges and Opportunities Ahead for Psychemedics Corporation in 2024

The stock market is an ever-changing landscape, influenced by a myriad of factors including financial performance, strategic decisions, and market conditions. One company that recently made headlines in the stock market is Psychemedics Corporation (NASDAQ: PMD), a leading provider of hair testing for drugs of abuse. They announced their financial results for the year ended December 31, 2023, revealing some interesting facts.
One of the standout figures from their fiscal report is the widening of their PMD Deficit. For the fiscal span ending December 31, 2023, the deficit increased to $-0.13 per share, compared to $-0.08 the previous year. On a positive note, the company's EPS (Earnings Per Share) improved from $-0.36 per share in the previous reporting period.

Aclarion Inc

nACONs: short for Aclarion Inc investors and stakeholders

Aclarion Inc, a healthcare technology company that specializes in leveraging biomarkers and proprietary augmented intelligence algorithms, recently reported its financial performance for the fiscal fourth quarter of 2023. The results showed a decline in earnings per share compared to the previous year and the prior financial reporting period. This is a concerning trend for the company, as it signifies a decrease in profitability.
During the fiscal fourth quarter of 2023, Aclarion Inc reached earnings per share of $0.00, the same as the previous year. However, when compared to the prior financial reporting period, there was no change. This indicates stagnation in terms of earnings growth for the company. Revenue for the quarter also declined by 38.734% to $0.01 million from $0.02 million in the same period a year ago. Additionally, sequentially, revenue fell by 27.632% from $0.02 million.



About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com